Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy

Paclitaxel (PTX) has shown pleiotropic immunologic effects on the tumor microenvironment, and nanomicelle has emerged as a promising strategy for PTX delivery. However, the detailed mechanisms remain to be fully elucidated. Meanwhile, immunogenic cell death (ICD) is an effective approach to activate...

詳細記述

保存先:
書誌詳細
出版年:Theranostics
主要な著者: Yang, Qianmei, Shi, Gang, Chen, Xiaolei, Lin, Yi, Cheng, Lin, Jiang, Qingyuan, Yan, Xi, Jiang, Ming, Li, Yiming, Zhang, Hantao, Wang, Huiling, Wang, Yuan, Wang, Qingnan, Zhang, Yujing, Liu, Yi, Su, Xiaolan, Dai, Lei, Tang, Minghai, Li, Jia, Zhang, Lan, Qian, Zhiyong, Yu, Dechao, Deng, Hongxin
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2020
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7381738/
https://ncbi.nlm.nih.gov/pubmed/32724476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.45391
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料